Roche says weight loss drug shows promising results in early trial
The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after
Read More
Health care industry
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
Novavax said the deal with Sanofi allows it to remove its "going concern" warning, which it first issued last year
Read More
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
President Emmanuel Macron will kick off the annual 'Choose France' event aimed at wooing big overseas businesses and investors on
Read More
Paid time off for pregnant women could go national as work movement, led by New York
Paid leave from work for prenatal care is poised to see a national push after New York became the first
Read More
Moderna says FDA delayed RSV vaccine approval to end of May
The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent
Read More
Novavax shares spike over 100% on Sanofi deal to commercialize Covid vaccine, develop combination shots
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having
Read More
Neuralink’s first in-human brain implant has experienced a problem, company says
Neuralink on Wednesday said part of its brain implant has malfunctioned within human patient. Source link
Read More
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments. Source link
Read More
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and
Read More